About
Accurate targeting mechanism combined with lethal payloads, antibody-drug conjugates (ADCs) have become a new wave of next-generation immune therapeutics that are tipping the scale in the battle against cancer. Bearing similar concept, various forms of antibody (scFv, Fab, chimeric antibody, Fc-fusion protein…), referred to as “guidance chimeras”, can also be engineered into payload bearing warheads.
Following
(20)
Followers
(1)
Likes
(2)
Groups
(1)
Crop your avatar
